NEUVOGEN
Live / Registered — Registered (as of 03 Mar 2026)
What this means for you
Registered since 03 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88985509
- Registration number
- 8161413
- Mark type
- Stylized text
- Filed
- 25 Mar 2020
- Published for opposition
- 31 Dec 2024
- Registered
- 03 Mar 2026
- Attorney of record
- Bret J. Danow
Goods and services
- Class 042 — Scientific and technological services: Research and development of vaccines and medicines
Owner
- NEUVOGEN, INC., SAN DIEGO, CA, US
- NEUVOGEN, INC., SAN DIEGO, CA, US
- NEUVOGEN, INC., SAN DIEGO, CA, US
- ImmunoActiva, Inc., San Diego, CA, US
Prosecution history
- 03 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 10 Feb 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Feb 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Feb 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Aug 2025 — USE AMENDMENT FILED
- 09 Feb 2026 — DIVISIONAL PROCESSING COMPLETE
- 18 Aug 2025 — DIVISIONAL REQUEST RECEIVED
- 27 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Aug 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 18 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
- 25 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 31 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Dec 2024 — PUBLISHED FOR OPPOSITION
- 25 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED